APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Glycosidases

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Glycosidases Market Outlook and Growth Opportunities 2026

Report ID 17442503054 July 2026200 pages

Choose your research edition.

Industry ResearchGlycosidases Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Glycosidases Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Glycosidases Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glycosidases Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Glycosidases Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Glycosidases market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Glycosidases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Glycosidases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glycosidases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Glycosidases market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Glycosidases market include Thermo Fisher Scientific, Waters Corporation, Vaupell Holdings, Takara Bio, Sumitomo Bakelite, Shimadzu Analytical, S-BIO, RayBiotech and RandD Systems, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Glycosidases market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Glycosidases and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Glycosidases sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glycosidases market size, projected growth trends, production technologies, key applications, and end-use industries.

Glycosidases Segment by Company

Thermo Fisher Scientific

Waters Corporation

Vaupell Holdings

Takara Bio

Sumitomo Bakelite

Shimadzu Analytical

S-BIO

RayBiotech

RandD Systems

PerkinElmer

New England Biolabs

Merck Group

Geno Technology

FUJIFILM Wako Pure Chemical Corporation

Danaher

Cambridge Isotope Laboratories

Bruker

Agilent Technologies

Glycosidases Segment by Type

Endoglycosidase

Exoglycosidase

Glycosidases Segment by Application

Academic Research Institutes

Pharmaceutical And Biotechnology Companies

Others

Glycosidases Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Glycosidases status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Glycosidases market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Glycosidases significant trends, drivers, influence factors in global and regions.

6. To analyze Glycosidases competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glycosidases market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glycosidases and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glycosidases.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Glycosidases market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Glycosidases industry.

Chapter 3: Detailed analysis of Glycosidases manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Glycosidases in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Glycosidases in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Glycosidases Industry Trends Table 2. Glycosidases Industry Drivers Table 3. Glycosidases Industry Opportunities and Challenges Table 4. Glycosidases Industry Restraints Table 5. Global Glycosidases Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Glycosidases Revenue Share by Company (2021-2026) Table 7. Global Glycosidases Sales Volume by Company (k units) & (2021-2026) Table 8. Global Glycosidases Sales Volume Share by Company (2021-2026) Table 9. Global Glycosidases Average Price (USD/unit) of Company (2021-2026) Table 10. Global Glycosidases Company Ranking, (2024-2026) & (USD Million) Table 11. Global Glycosidases Key Company Manufacturing Base & Headquarters Table 12. Global Glycosidases Company, Product Type & Application Table 13. Global Glycosidases Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Glycosidases by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Endoglycosidase Table 18. Significant Companies of Exoglycosidase Table 19. Global Glycosidases Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Glycosidases Sales Volume by Type (2021-2026) & (k units) Table 21. Global Glycosidases Sales Volume by Type (2027-2032) & (k units) Table 22. Global Glycosidases Sales Volume Share by Type (2021-2026) Table 23. Global Glycosidases Sales Volume Share by Type (2027-2032) Table 24. Global Glycosidases Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Glycosidases Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Glycosidases Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Glycosidases Sales Value Share by Type (2021-2026) Table 28. Global Glycosidases Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Academic Research Institutes Table 30. Significant Companies of Pharmaceutical And Biotechnology Companies Table 31. Significant Companies of Others Table 32. Global Glycosidases Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Glycosidases Sales Volume by Application (2021-2026) & (k units) Table 34. Global Glycosidases Sales Volume by Application (2027-2032) & (k units) Table 35. Global Glycosidases Sales Volume Share by Application (2021-2026) Table 36. Global Glycosidases Sales Volume Share by Application (2027-2032) Table 37. Global Glycosidases Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Glycosidases Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Glycosidases Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Glycosidases Sales Value Share by Application (2021-2026) Table 41. Global Glycosidases Sales Value Share by Application (2027-2032) Table 42. Global Glycosidases Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Glycosidases Sales by Region (2021-2026) & (k units) Table 44. Global Glycosidases Sales Market Share by Region (2021-2026) Table 45. Global Glycosidases Sales by Region (2027-2032) & (k units) Table 46. Global Glycosidases Sales Market Share by Region (2027-2032) Table 47. Global Glycosidases Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Glycosidases Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Glycosidases Sales Value Share by Region (2021-2026) Table 50. Global Glycosidases Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Glycosidases Sales Value Share by Region (2027-2032) Table 52. Global Glycosidases Market Average Price (USD/unit) by Region (2021-2026) Table 53. Global Glycosidases Market Average Price (USD/unit) by Region (2027-2032) Table 54. Global Glycosidases Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Glycosidases Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Glycosidases Sales by Country (2021-2026) & (k units) Table 57. Global Glycosidases Sales Market Share by Country (2021-2026) Table 58. Global Glycosidases Sales by Country (2027-2032) & (k units) Table 59. Global Glycosidases Sales Market Share by Country (2027-2032) Table 60. Global Glycosidases Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Glycosidases Sales Value Market Share by Country (2021-2026) Table 62. Global Glycosidases Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Glycosidases Sales Value Market Share by Country (2027-2032) Table 64. Thermo Fisher Scientific Company Information Table 65. Thermo Fisher Scientific Business Overview Table 66. Thermo Fisher Scientific Glycosidases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 67. Thermo Fisher Scientific Glycosidases Product Portfolio Table 68. Thermo Fisher Scientific Recent Development Table 69. Waters Corporation Company Information Table 70. Waters Corporation Business Overview Table 71. Waters Corporation Glycosidases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 72. Waters Corporation Glycosidases Product Portfolio Table 73. Waters Corporation Recent Development Table 74. Vaupell Holdings Company Information Table 75. Vaupell Holdings Business Overview Table 76. Vaupell Holdings Glycosidases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. Vaupell Holdings Glycosidases Product Portfolio Table 78. Vaupell Holdings Recent Development Table 79. Takara Bio Company Information Table 80. Takara Bio Business Overview Table 81. Takara Bio Glycosidases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. Takara Bio Glycosidases Product Portfolio Table 83. Takara Bio Recent Development Table 84. Sumitomo Bakelite Company Information Table 85. Sumitomo Bakelite Business Overview Table 86. Sumitomo Bakelite Glycosidases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Sumitomo Bakelite Glycosidases Product Portfolio Table 88. Sumitomo Bakelite Recent Development Table 89. Shimadzu Analytical Company Information Table 90. Shimadzu Analytical Business Overview Table 91. Shimadzu Analytical Glycosidases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Shimadzu Analytical Glycosidases Product Portfolio Table 93. Shimadzu Analytical Recent Development Table 94. S-BIO Company Information Table 95. S-BIO Business Overview Table 96. S-BIO Glycosidases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. S-BIO Glycosidases Product Portfolio Table 98. S-BIO Recent Development Table 99. RayBiotech Company Information Table 100. RayBiotech Business Overview Table 101. RayBiotech Glycosidases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. RayBiotech Glycosidases Product Portfolio Table 103. RayBiotech Recent Development Table 104. RandD Systems Company Information Table 105. RandD Systems Business Overview Table 106. RandD Systems Glycosidases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. RandD Systems Glycosidases Product Portfolio Table 108. RandD Systems Recent Development Table 109. PerkinElmer Company Information Table 110. PerkinElmer Business Overview Table 111. PerkinElmer Glycosidases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. PerkinElmer Glycosidases Product Portfolio Table 113. PerkinElmer Recent Development Table 114. New England Biolabs Company Information Table 115. New England Biolabs Business Overview Table 116. New England Biolabs Glycosidases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. New England Biolabs Glycosidases Product Portfolio Table 118. New England Biolabs Recent Development Table 119. Merck Group Company Information Table 120. Merck Group Business Overview Table 121. Merck Group Glycosidases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Merck Group Glycosidases Product Portfolio Table 123. Merck Group Recent Development Table 124. Geno Technology Company Information Table 125. Geno Technology Business Overview Table 126. Geno Technology Glycosidases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Geno Technology Glycosidases Product Portfolio Table 128. Geno Technology Recent Development Table 129. FUJIFILM Wako Pure Chemical Corporation Company Information Table 130. FUJIFILM Wako Pure Chemical Corporation Business Overview Table 131. FUJIFILM Wako Pure Chemical Corporation Glycosidases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. FUJIFILM Wako Pure Chemical Corporation Glycosidases Product Portfolio Table 133. FUJIFILM Wako Pure Chemical Corporation Recent Development Table 134. Danaher Company Information Table 135. Danaher Business Overview Table 136. Danaher Glycosidases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. Danaher Glycosidases Product Portfolio Table 138. Danaher Recent Development Table 139. Cambridge Isotope Laboratories Company Information Table 140. Cambridge Isotope Laboratories Business Overview Table 141. Cambridge Isotope Laboratories Glycosidases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. Cambridge Isotope Laboratories Glycosidases Product Portfolio Table 143. Cambridge Isotope Laboratories Recent Development Table 144. Bruker Company Information Table 145. Bruker Business Overview Table 146. Bruker Glycosidases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 147. Bruker Glycosidases Product Portfolio Table 148. Bruker Recent Development Table 149. Agilent Technologies Company Information Table 150. Agilent Technologies Business Overview Table 151. Agilent Technologies Glycosidases Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 152. Agilent Technologies Glycosidases Product Portfolio Table 153. Agilent Technologies Recent Development Table 154. Key Raw Materials Table 155. Raw Materials Key Suppliers Table 156. Glycosidases Distributors List Table 157. Glycosidases Customers List Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources Table 161. Primary Sources List of Figures Figure 1. Glycosidases Product Image Figure 2. Global Glycosidases Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glycosidases Sales Value (2021-2032) & (US$ Million) Figure 4. Global Glycosidases Sales (2021-2032) & (k units) Figure 5. Global Glycosidases Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Glycosidases Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Endoglycosidase Image Figure 10. Exoglycosidase Image Figure 11. Global Glycosidases Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Glycosidases Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Glycosidases Sales Volume Share by Type (2021-2032) Figure 14. Global Glycosidases Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Glycosidases Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Glycosidases Sales Value Share by Type (2021-2032) Figure 17. Academic Research Institutes Image Figure 18. Pharmaceutical And Biotechnology Companies Image Figure 19. Others Image Figure 20. Global Glycosidases Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Glycosidases Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Glycosidases Sales Volume Share by Application (2021-2032) Figure 23. Global Glycosidases Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Glycosidases Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Glycosidases Sales Value Share by Application (2021-2032) Figure 26. Global Glycosidases Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Glycosidases Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Glycosidases Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Glycosidases Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Glycosidases Sales Value (2021-2032) & (US$ Million) Figure 31. North America Glycosidases Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Glycosidases Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Glycosidases Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Glycosidases Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Glycosidases Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Glycosidases Sales Value (2021-2032) & (US$ Million) Figure 37. South America Glycosidases Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Glycosidases Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Glycosidases Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Glycosidases Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Glycosidases Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Glycosidases Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Glycosidases Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Glycosidases Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Endoglycosidase
  • Exoglycosidase
Applications
  • Academic Research Institutes
  • Pharmaceutical And Biotechnology Companies
  • Others
Companies covered
  • Thermo Fisher Scientific
  • Waters Corporation
  • Vaupell Holdings
  • Takara Bio
  • Sumitomo Bakelite
  • Shimadzu Analytical
  • S-BIO
  • RayBiotech
  • RandD Systems
  • PerkinElmer
  • New England Biolabs
  • Merck Group
  • Geno Technology
  • FUJIFILM Wako Pure Chemical Corporation
  • Danaher
  • Cambridge Isotope Laboratories
  • Bruker
  • Agilent Technologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glycosidases Sales Value (2021-2032)
  4. 1.2.2 Global Glycosidases Sales Volume (2021-2032)
  5. 1.2.3 Global Glycosidases Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Glycosidases Market Dynamics
  1. 2.1 Glycosidases Industry Trends
  2. 2.2 Glycosidases Industry Drivers
  3. 2.3 Glycosidases Industry Opportunities and Challenges
  4. 2.4 Glycosidases Industry Restraints
3 Glycosidases Market by Company
  1. 3.1 Global Glycosidases Company Revenue Ranking in 2025
  2. 3.2 Global Glycosidases Revenue by Company (2021-2026)
  3. 3.3 Global Glycosidases Sales Volume by Company (2021-2026)
  4. 3.4 Global Glycosidases Average Price by Company (2021-2026)
  5. 3.5 Global Glycosidases Company Ranking (2024-2026)
  6. 3.6 Global Glycosidases Company Manufacturing Base and Headquarters
  7. 3.7 Global Glycosidases Company Product Type and Application
  8. 3.8 Global Glycosidases Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Glycosidases Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Glycosidases Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Glycosidases Market by Type
  1. 4.1 Glycosidases Type Introduction
  2. 4.1.1 Endoglycosidase
  3. 4.1.2 Exoglycosidase
  4. 4.2 Global Glycosidases Sales Volume by Type
  5. 4.2.1 Global Glycosidases Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Glycosidases Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Glycosidases Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Glycosidases Sales Value by Type
  9. 4.3.1 Global Glycosidases Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Glycosidases Sales Value by Type (2021-2032)
  11. 4.3.3 Global Glycosidases Sales Value Share by Type (2021-2032)
5 Glycosidases Market by Application
  1. 5.1 Glycosidases Application Introduction
  2. 5.1.1 Academic Research Institutes
  3. 5.1.2 Pharmaceutical And Biotechnology Companies
  4. 5.1.3 Others
  5. 5.2 Global Glycosidases Sales Volume by Application
  6. 5.2.1 Global Glycosidases Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Glycosidases Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Glycosidases Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Glycosidases Sales Value by Application
  10. 5.3.1 Global Glycosidases Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Glycosidases Sales Value by Application (2021-2032)
  12. 5.3.3 Global Glycosidases Sales Value Share by Application (2021-2032)
6 Glycosidases Regional Sales and Value Analysis
  1. 6.1 Global Glycosidases Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Glycosidases Sales by Region (2021-2032)
  3. 6.2.1 Global Glycosidases Sales by Region: 2021-2026
  4. 6.2.2 Global Glycosidases Sales by Region (2027-2032)
  5. 6.3 Global Glycosidases Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Glycosidases Sales Value by Region (2021-2032)
  7. 6.4.1 Global Glycosidases Sales Value by Region: 2021-2026
  8. 6.4.2 Global Glycosidases Sales Value by Region (2027-2032)
  9. 6.5 Global Glycosidases Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Glycosidases Sales Value (2021-2032)
  12. 6.6.2 North America Glycosidases Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Glycosidases Sales Value (2021-2032)
  15. 6.7.2 Europe Glycosidases Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Glycosidases Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Glycosidases Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Glycosidases Sales Value (2021-2032)
  21. 6.9.2 South America Glycosidases Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Glycosidases Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Glycosidases Sales Value Share by Country, 2025 VS 2032
7 Glycosidases Country-level Sales and Value Analysis
  1. 7.1 Global Glycosidases Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Glycosidases Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Glycosidases Sales by Country (2021-2032)
  4. 7.3.1 Global Glycosidases Sales by Country (2021-2026)
  5. 7.3.2 Global Glycosidases Sales by Country (2027-2032)
  6. 7.4 Global Glycosidases Sales Value by Country (2021-2032)
  7. 7.4.1 Global Glycosidases Sales Value by Country (2021-2026)
  8. 7.4.2 Global Glycosidases Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Glycosidases Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Glycosidases Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Glycosidases Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Glycosidases Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Glycosidases Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Glycosidases Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Glycosidases Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Glycosidases Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Glycosidases Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Glycosidases Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Glycosidases Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Glycosidases Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Glycosidases Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Glycosidases Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Glycosidases Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Glycosidases Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Glycosidases Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Glycosidases Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Glycosidases Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Glycosidases Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Glycosidases Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Glycosidases Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Glycosidases Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Glycosidases Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Glycosidases Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Glycosidases Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Glycosidases Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Glycosidases Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Glycosidases Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Glycosidases Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Glycosidases Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Glycosidases Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Glycosidases Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Glycosidases Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Glycosidases Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Glycosidases Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Glycosidases Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Glycosidases Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Glycosidases Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Glycosidases Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Glycosidases Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Glycosidases Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Glycosidases Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Glycosidases Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Glycosidases Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Glycosidases Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Glycosidases Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Glycosidases Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Glycosidases Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Glycosidases Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Glycosidases Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Glycosidases Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Glycosidases Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Glycosidases Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Glycosidases Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Glycosidases Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Glycosidases Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Glycosidases Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Glycosidases Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Glycosidases Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Glycosidases Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Glycosidases Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Glycosidases Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Glycosidases Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Glycosidases Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Glycosidases Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Glycosidases Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Glycosidases Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Glycosidases Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Glycosidases Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Glycosidases Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Glycosidases Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Glycosidases Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Glycosidases Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Glycosidases Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Glycosidases Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Glycosidases Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Glycosidases Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Glycosidases Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Glycosidases Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Glycosidases Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Glycosidases Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Glycosidases Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Glycosidases Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Glycosidases Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Glycosidases Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Waters Corporation
  8. 8.2.1 Waters Corporation Company Information
  9. 8.2.2 Waters Corporation Business Overview
  10. 8.2.3 Waters Corporation Glycosidases Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Waters Corporation Glycosidases Product Portfolio
  12. 8.2.5 Waters Corporation Recent Developments
  13. 8.3 Vaupell Holdings
  14. 8.3.1 Vaupell Holdings Company Information
  15. 8.3.2 Vaupell Holdings Business Overview
  16. 8.3.3 Vaupell Holdings Glycosidases Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Vaupell Holdings Glycosidases Product Portfolio
  18. 8.3.5 Vaupell Holdings Recent Developments
  19. 8.4 Takara Bio
  20. 8.4.1 Takara Bio Company Information
  21. 8.4.2 Takara Bio Business Overview
  22. 8.4.3 Takara Bio Glycosidases Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Takara Bio Glycosidases Product Portfolio
  24. 8.4.5 Takara Bio Recent Developments
  25. 8.5 Sumitomo Bakelite
  26. 8.5.1 Sumitomo Bakelite Company Information
  27. 8.5.2 Sumitomo Bakelite Business Overview
  28. 8.5.3 Sumitomo Bakelite Glycosidases Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sumitomo Bakelite Glycosidases Product Portfolio
  30. 8.5.5 Sumitomo Bakelite Recent Developments
  31. 8.6 Shimadzu Analytical
  32. 8.6.1 Shimadzu Analytical Company Information
  33. 8.6.2 Shimadzu Analytical Business Overview
  34. 8.6.3 Shimadzu Analytical Glycosidases Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Shimadzu Analytical Glycosidases Product Portfolio
  36. 8.6.5 Shimadzu Analytical Recent Developments
  37. 8.7 S-BIO
  38. 8.7.1 S-BIO Company Information
  39. 8.7.2 S-BIO Business Overview
  40. 8.7.3 S-BIO Glycosidases Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 S-BIO Glycosidases Product Portfolio
  42. 8.7.5 S-BIO Recent Developments
  43. 8.8 RayBiotech
  44. 8.8.1 RayBiotech Company Information
  45. 8.8.2 RayBiotech Business Overview
  46. 8.8.3 RayBiotech Glycosidases Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 RayBiotech Glycosidases Product Portfolio
  48. 8.8.5 RayBiotech Recent Developments
  49. 8.9 RandD Systems
  50. 8.9.1 RandD Systems Company Information
  51. 8.9.2 RandD Systems Business Overview
  52. 8.9.3 RandD Systems Glycosidases Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 RandD Systems Glycosidases Product Portfolio
  54. 8.9.5 RandD Systems Recent Developments
  55. 8.10 PerkinElmer
  56. 8.10.1 PerkinElmer Company Information
  57. 8.10.2 PerkinElmer Business Overview
  58. 8.10.3 PerkinElmer Glycosidases Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 PerkinElmer Glycosidases Product Portfolio
  60. 8.10.5 PerkinElmer Recent Developments
  61. 8.11 New England Biolabs
  62. 8.11.1 New England Biolabs Company Information
  63. 8.11.2 New England Biolabs Business Overview
  64. 8.11.3 New England Biolabs Glycosidases Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 New England Biolabs Glycosidases Product Portfolio
  66. 8.11.5 New England Biolabs Recent Developments
  67. 8.12 Merck Group
  68. 8.12.1 Merck Group Company Information
  69. 8.12.2 Merck Group Business Overview
  70. 8.12.3 Merck Group Glycosidases Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Merck Group Glycosidases Product Portfolio
  72. 8.12.5 Merck Group Recent Developments
  73. 8.13 Geno Technology
  74. 8.13.1 Geno Technology Company Information
  75. 8.13.2 Geno Technology Business Overview
  76. 8.13.3 Geno Technology Glycosidases Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Geno Technology Glycosidases Product Portfolio
  78. 8.13.5 Geno Technology Recent Developments
  79. 8.14 FUJIFILM Wako Pure Chemical Corporation
  80. 8.14.1 FUJIFILM Wako Pure Chemical Corporation Company Information
  81. 8.14.2 FUJIFILM Wako Pure Chemical Corporation Business Overview
  82. 8.14.3 FUJIFILM Wako Pure Chemical Corporation Glycosidases Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 FUJIFILM Wako Pure Chemical Corporation Glycosidases Product Portfolio
  84. 8.14.5 FUJIFILM Wako Pure Chemical Corporation Recent Developments
  85. 8.15 Danaher
  86. 8.15.1 Danaher Company Information
  87. 8.15.2 Danaher Business Overview
  88. 8.15.3 Danaher Glycosidases Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Danaher Glycosidases Product Portfolio
  90. 8.15.5 Danaher Recent Developments
  91. 8.16 Cambridge Isotope Laboratories
  92. 8.16.1 Cambridge Isotope Laboratories Company Information
  93. 8.16.2 Cambridge Isotope Laboratories Business Overview
  94. 8.16.3 Cambridge Isotope Laboratories Glycosidases Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Cambridge Isotope Laboratories Glycosidases Product Portfolio
  96. 8.16.5 Cambridge Isotope Laboratories Recent Developments
  97. 8.17 Bruker
  98. 8.17.1 Bruker Company Information
  99. 8.17.2 Bruker Business Overview
  100. 8.17.3 Bruker Glycosidases Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Bruker Glycosidases Product Portfolio
  102. 8.17.5 Bruker Recent Developments
  103. 8.18 Agilent Technologies
  104. 8.18.1 Agilent Technologies Company Information
  105. 8.18.2 Agilent Technologies Business Overview
  106. 8.18.3 Agilent Technologies Glycosidases Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Agilent Technologies Glycosidases Product Portfolio
  108. 8.18.5 Agilent Technologies Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Glycosidases Value Chain Analysis
  2. 9.1.1 Glycosidases Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Glycosidases Sales Mode & Process
  6. 9.2 Glycosidases Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Glycosidases Distributors
  9. 9.2.3 Glycosidases Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst